Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
PHASE3
To compare the effect on glycemic control (HbA1c) of exenatide suspension a...
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
PHASE4
SGLT2 antagonists and GLP1 agonists are used since a relatively short perio...
Status
Completed
Location
Abt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Medizin III
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
PHASE3
Study D5553C00002 is a multicenter, randomized, double-blind, placebo-contr...